Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: Preclinical studies in a murine model recapitulating philadelphia chromosome-positive acute lymphoblastic leukemia

Human Gene Therapy

Volumn 10, Issue 13, 1999, Pages 2109-2122

  Stripecke, R ^a,b   Skelton, D C ^a   Pattengale, P K ^a   Shimada, H ^a   Kohn, D B ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CANCER VACCINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL LINE; CONTROLLED STUDY; IMMUNIZATION; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; IRRADIATION; MALE; MOUSE; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; PROTEIN EXPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION; VACCINATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; CANCER VACCINES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INTERLEUKIN-2; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033198912     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017103     Document Type: Article

References (52)

1. BOCCHIA, M., KORONRSVIT, T., XU, Q., MACKKINNON, S., YOUNG YANG, S., SETTE, A., and SCHEINBERG, D.A. (1996). Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 87, 3587-3592.
2. BUNNEL, B.A., MULL, L.M., DONAHUE, R.E., BLAESE, R.M., and MORGAN, R.A. (1995). High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 7739-7743.
3. BUZYN, A., OSTANKOVITCH, M., ZERBIB, A., KEMULA, M., CONNAN, F., VARET, B., GUILLET, J.-G., and CHOPPIN, J. (1997). Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes. Eur. J. Immunol. 27, 2066-2072.
4. CARDOSO, A.A., SCHULTZE, J.L., BOUSSIOTIS, V.A., FREEMAN, G.J., SEAMON, M.J., LASZLO, S., BILLET, A., SALLAN, S.E., GRIBBEN, J.G., and NADLER, L.M. (1996). Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood 88, 41-48.
5. CARDOSO, A.A., SEAMON, M.J., AFONSO, H.M., GHIA, P., BOUSSIOTIS, V.A., FREEMAN, B.J., GRIBBEN, J.G., SALLAN, S.E., and NADLER, L.M. (1997). Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells. Blood 90, 549-561.
6. CAUX, C., DEZUTTER-DAMBUYANT, C., SCHITT, D., and BANCHEREAU, J. (1992). GM-CSF and TNF-alfa cooperate in the generation of dendritic Langerhans cells. Nature (London) 360, 258-261.
7. CHONG, H., TODRYK, S., HUTCHINSON, G., HART, I.R., and VILE, R.G. (1998). Tumor cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumor response and may generate systemic protective immunity. Gene Ther. 5, 223-232.
8. COLEMAN, D.L., CHODAKEWITZ, J.A., BARTISS, A.H., and MELLORS, J.W. (1988). Granulocyte-macrophage colony-stimulating factor enhances selective effector functions of tissue-derived macrophages. Blood 72, 573.
9. DE WIT, D., FLEMMING, C.L., HARRIS, J.D., PALMER, K.J., MOORE, J.S., GORE, M.E., and COLLINS, M.K. (1996). IL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL). Clin. Exp. Immunol. 105, 353-359.
10. DILLOO, D., RILL, D., ENTWISTLE, C., BOURSNELL, M., ZHONG, W., HOLDEN, W., HOLLADAY, M., INGLIS, S., and BRENNER, M. (1997). A novel herpes vector for the high-efficiency transduction of normal and malignant human hematopoietic cells. Blood 89, 119-127.
11. DRANOFF, G. (1997). Clinical protocol: A phase I study of vaccination with autologous irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor. Hum. Gene Ther. 7, 111-123.
12. DRANOFF, G., JAFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90, 3539-3543.
13. DUNUSSI-JOANNOPOULOS, K., WEINSTEIN, H.J., NICKERSON, P.W., STROM. T.B., BUKAROFF, J., CROOP, J.M., and ARCECI, R.J. (1996). Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. Blood 87, 2938-2946.
14. DUNUSSI-JOANNOPOULOS, K., DRANOFF, G., WEINSTEIN, H.J., FERRARA, J.L., BIERER, B.E., and CROOP, J.M. (1998). Gene immunotherapy in murine acute myeloid leukemia: Granulocyte-macrophage colony-stimulating factor in tumor cell vaccines elicits more potent antitumor immunity compared with B7 family and other cytokine vaccines. Blood 91, 222-230.
15. FEARON, E.R., PARDOLL, D.M., ITAYA, T., GOLUMBEK, P., LEVITSKY, H.I., SIMONS, J.W., KARSUYAMA, H., VOGELSTEIN, B., and FROST, P. (1990). Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60, 397-403.
16. FLEISS, J.L. (1981). The comparison of proportions from several independent samples. In Statistical Methods for Rates and Proportions. J.L. Fleiss, ed. (John Wiley & Sons, New York) pp. 138-159.
17. GAMBACORTI-PASSERINI, C., BERTAZZOLI, C., DERMIME, S., SCARDINO, A., SCHENDEL, D., and PARMIANI, G. (1997). Mapping of HLA class I binding motifs in fourty-four fusion proteins involved in human cancers. Clin. Cancer Res. 3, 675-683.
18. GRECO, G., FRUCI, D., ACCAPEZZATO, D., BARNABA, V., NISINI, R., ALIMENA, G., MONTEFUSCO, E., VIGENTI. E., BUTLER. R., TANIGAKI, N., and TOSI, R. (1996). Two bcr-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes. Leukemia 10, 693-699.
19. HEUFLER, C., KOCH, F., and SCHULER, G. (1988). Granulocyte-macrophage colony stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167, 700-705.
20. HIRANO, N., TAKASHI, T., OHTAKE, S., HIRASHIMA, K., EMI, N., SAITO, K., HIRANO, M., SHINOHARA, K., TAKEUSH, M., TAKETAZU, F., TSUNODA, S., OGURA, M., OMINE, M., SAITO, T., YAZAKI, Y., UEDA, R., and HIRAI, H. (1996). Expression of costimulatory molecules in human leukemias. Leukemia 10, 1168-1176.
21. HURWITZ, A.A., TOWNSEND, S.E., YU, T.F., WALLIN, J.A., and ALLISON, J.P. (1998). Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinoma. Int. J. Cancer 77, 107-113.
22. JAFFEE, E.M. (1998). Clinical protocol: A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma. Hum. Gene Ther. 9, 1951-1971.
23. KONG, H.-L., HECHT, D., SONG, W., KOVESDI, I., HACKETT, N.R., YAYON, A., and CRYSTAL, R.G. (1998). Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. Hum. Gene Ther. 9, 823-833.
24. KRUGER, M., GOOL, S., PENG, X.H., COOREVITS, L., CASTEELS-VAN DAELE, M., and CEUPPENS, J.L. (1996). Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta. Immunology 88, 49-54.
25. LARSEN, C.P., RITCHIE, S.C., HENDRIX, R., LINSLEY, P.S., HATHCOCK, K.S., HODES, R.J., LOWRY, R.P., and PEARSON, T. (1994). Regulation of immunostimulatory function and costimulatory moleculae (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152, 5208-5219.
26. LEVITSKY, H.I., MONTGOMERY, J., AHMADAZEH, M., STAVELEY O'CARROL, K., GUARNIERI, F., LONGO, D.L., and KWAK, L.W. (1996). Immunization with GM-CSF-transduced, but not B7-1-transduced lymphoma cells primes idiotype-specific T cells and generates potent anti-tumor immunity. J. Immunol. 156, 3858-3865.
27. LINSLEY, P.S., BRADY, W., GROSMAIRE, L., ARUFFO, A., DAMLE, N.K., and LEDBETTER, J.A. (1991). Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 mRNA accumulation. J. Exp. Med. 173, 721-730.
28. LOPEZ, A.F., WILLIAMSON, D.J., GAMBLE, J.R., BEGLEY, C.G., HARLAN, J.M., KLEBANOFF, S.J., WALTERSDORPH, A., WONG, G., CLARK, S.C., and VADAS, M.A. (1986). Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression and survival. J. Clin. Invest. 78, 1220-1228.
29. MARKOWITZ, D., GOFF, S., and BANK, A. (1988). A safe packaging line for gene transfer:separating viral genes on two different plasmids. J. Virol. 62, 1120-1124.
30. MASCARENHAS, L., STRIPECKE, R., CASE, S.C., XU, D., WEINBERG, K.I., and KOHN, D.B. (1998). Gene delivery to human precursor acute lymphoblastic leukemia cells. Blood 92, 3537-3545.
31. MASUCCI, G., WERSALL, P., RANGHAMMAR, P., and MELLSTED, H. (1989). Granulocyte-monocyte colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity. Cancer Immunol. Immunother. 29, 288-292.
32. MATULONIS, U.A., DOSIOU, C., LAMONT, C., FREEMAN, G.J., MAUCH, P., NADLER, L.M., and GRIFFIN, J.D. (1995). Role of B7-1 in mediating an immune response to myeloid leukemia cells. Blood 85, 2507-2515.
33. MELO, J. (1996). The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88, 2375-2384.
34. MOLLDREM, J.J., CLAVE, E., JIANG, Y.Z., MAVROUDIS, D., RAPTIS, A., HENSEL, N., AGARWALA, V., and BARRET, A.J. (1997). Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units. Blood 90, 2529-2534.
35. PAPADOUPOLOUS, K.P., SUCIU-FOCA, N., HESDORFFER, C.S., TUGULEA, S., MAFFEI, A., and HARRIS, P. (1997). Naturally processed tissue- and differentiation stage-specific autologous peptides bound to HLA class I and II molecules of chronic myeloid leukemia blasts. Blood 90, 4938-4946.
36. PHILLIPS, J.H., and LANIER, L.L. (1986). Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J. Exp. Med. 164, 814-825.
37. ROMANI, N., KOIDE, S., CROWLELEY, M., WITMER-PACK, M., LIVINGSTONE, A.M., FATHMAN, C.G., INABA, K., and STEINMAN, R.M. (1989). Presentation of exogenous protein antigens by dendritic cells to T cell clones: Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169, 1169-1178.
38. SALLUSTO, F., and LANZAVECCHIA, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte-macrophage colony stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor-alfa. J. Exp. Med. 179, 1109-1118.
39. SALVADORI, S., GANSBACHER, B., WERNICK, I., TIRELLI, S., and ZIER, K. (1995). B7-1 amplifies the response to interleukin-2 secreting tumor vaccines in vivo, but fails to induce a response to naive cells in vitro. Hum. Gene Ther. 6, 1299-1306.
40. SIMONS, J.W. (1995). Clinical protocol: Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum. Gene Ther. 6, 347-368.
41. SOIFFER, R., LYNCH, T., MIHM, M., JUNG, K., RHUDA, C., SCHMOLLINGER, J.C., HODI, F.S., LIEBSTER, L., LAM, P., MENTZER, S., SINGER, S., TANABE, K.K., COSIMI, A.B., DUDA, R., SOBER, A., BHAN, A., DALEY, J., NEUBERG, D., PARRY, G., ROKOVICH, J., RICHARDS, L., DRAYER, J., BERNS, A., CLIFT, S., COHEN, L.K., MULLIGAN, R.C., and DRANOFF, G. (1998). Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc. Natl. Acad. Sci. U.S.A. 95, 13141-13146.
42. STRIPECKE, R., SKELTON, D.C., GRUBER, T., AFAR, D., PATTENGALE, P., WITTE, O.N., and KOHN, D.B. (1998). Immune response to Philadelphia chromosome positive acute lymphoblastic leukemia induced by coexpression of CD80, GM-CSF and IL-2. Hum. Gene Ther. 9, 2049-2062.
43. SUMIMOTO, H., TANI, K., NAKAZANI, Y., TANABE, T., HIBINO, H., HAMADA, H., AZUMA, M., and ASANO, S, (1997). GM-CSF and B7-1 (CD80) co-stimulatory signals cooperate in the induction of effective anti-tumor immunity in syngeneic mice. Int. J. Cancer 73, 556-61.
44. SUMIMOTO, H., TANI, K., NAKAZAKI, Y., TANABE, T., HIBINO, H., WU, M.S., IZAWA, K., HAMADA, H., and ASANO, S. (1998). Superiority of interleukin-12 transduced murine lung cancer cells to GM-CSF of B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice. Cancer Gene Ther. 5, 29-37.
45. TAZI, A., BOUCHONET, F., GRANDSAIGNE, M., BOUMSELL, L., HANCE, A.J., and SOLER, P. (1993). Evidence that granulocyte-macrophage colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/langerhans cells in human lung and lung cancers. J. Clin. Invest 91, 566-576.
46. TOWNSED, S.E., SU, F.W., ATHERTON, J.M., and ALLISON, J.P. (1994). Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res. 54, 6477-6483.
47. UCKUN, F.M., NACHMAN, J.B., SATHER, H.N., SENSEL, M.G., KRAFT, P., STEINHERZ, P.G., LANGE, B., HUTCHINSON, R., REAMAN, G.H., GAYNON, P.S., and HEEREMA, N. (1997). Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy. Leuk. Lymph. 28, 1-6.
48. VIEWEG, J., and GILBOA, E. (1995). Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment. Cancer Invest. 13, 193-201.
49. WELTE, K., REITER, A., MEMPEL, K., PFETSCH, M., SCHWAB, G., SCHRAPPE, M., and RIEHM, H. (1996). A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Blood 87, 3143-3150.
50. WESTBROOK, C.A., HOOBERMAN, A.L., SPINO, C., DODGE, R.K., LARSON, R.A., DAVEY, F., WURSTER-HILL, D.H., SOBOL, R.E., SCHIFFER, C., and BLOOMFIELD, C.D. (1992). Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B Study (8762). Blood 80, 2983-2990.
51. WITMER-PACK, M.D., OLIVIER, W., VALINSKY, J., SCHULER, G., and STEINMAN, R.M. (1987). Granulocyte-macrophage colony stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 166, 1484-1498.
52. ZIER, K.S., and GANSBACHER, B. (1995). The impact of gene therapy on T cell function in cancer. Hum. Gene Ther. 6, 1259-1264.